| 产品详情 |
| Edit |   |
|---|
| Product Name | Recombinant Human Endothelial-Monocyte A Activating Polypeptide II (rHu EMAP-II) |
|---|
| Description | MW: 34,353 Da. Purity >98% by SDS-PAGE and HPLC analyses. EMAP-II is a tumor derived cytokine that exerts a wide range of activities on endothelial cells, monocytes and neutrophils. EMAP-II inhibits endothelial cell proliferation, vasculogenesis, neovessel formation, and can induce apoptosis. It is also chemotactic towards neutrophils and monocytes and induces myeloperoxidase activity from neutrophils. Of clinical importance, EMAP-II inhibits angiogenesis of vascular beds and suppresses the grow |
|---|
| Size | 0.005 mg, 0.02 mg, 1 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | [Endothelial-Monocyte Activating Polypeptide II; human EMAP-II; Human Endothelial-Monocyte Activating Polypeptide II] |
|---|
| Gene, Accession, CAS # | AIMP1; AIMP1; p43; HLD3; EMAP2; SCYE1; EMAPII; EMAP2; SCYE1; EMAP-2; EMAP-II, Gene ID: 9255, Accession: AAA62202.1 |
|---|
| Catalog # | MBS546043 |
|---|
| Price | |
|---|
| Order / More Info | Recombinant Human Endothelial-Monocyte A Activating Polypeptide II (rHu EMAP-II) from MYBIOSOURCE INC. |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|